Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trial
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2019 |
| Author/s |
author: Thomas M Barber David Russell-Jones Rory J. McCrimmon Melanie Davies |
| Publication date | June 18, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |